Dexetimide

Dexetimide
Clinical data
AHFS/Drugs.com International Drug Names
ATC code N04AA08 (WHO)
Identifiers
CAS Number 21888-98-2 N
PubChem (CID) 30843
IUPHAR/BPS 354
DrugBank DB08997 N
ChemSpider 28615 YesY
UNII 43477QYX3D YesY
KEGG D03711 YesY
ChEMBL CHEMBL1908364 N
Chemical and physical data
Formula C23H26N2O2
Molar mass 362.465 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Dexetimide (brand name Tremblex) is a piperidine anticholinergic. It is a muscarinic antagonist that is used to treat drug induced parkinsonism. Dexetimide was discovered at Janssen Pharmaceutica in 1968.[1][2]

References

  1. Dom, R.; Van Lommel, R.; Baro, F. (1971). "A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent". Acta Psychiatrica Scandinavica. 47 (4): 399–410. doi:10.1111/j.1600-0447.1971.tb03697.x. PMID 4947805.
  2. Huygens, H.; Vereecken, J. L.; Tanghe, A. (1973). "Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action". Psychiatria, neurologia, neurochirurgia. 76 (4): 251–259. PMID 4581374.


This article is issued from Wikipedia - version of the 4/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.